Table 4.
Predicted conservancy of the antigenic site by using IEDB conservancy analysis [31]
| Sequence | Identity % |
|---|---|
|
Bepipred analysis | |
| VRPGNFNQ |
17.39 |
| GNAAIT |
41.30 |
| DKSAGHPFN |
17.39 |
| SYQEQ |
17.39 |
| DVDNP |
41.30 |
| YPKCDRA |
100.00 |
| YYVKPGGTSSGDATTAY |
17.39 |
|
IEDB analysis | |
| DYKVQLFEKYFKY |
17.39 |
| HANCVNCTDDRCVLHCANFNVLFAM |
17.39 |
| KTCFGPIVRKIFVDGVPFVVSCGYHYKELGLV |
17.39 |
| VSLHRHRLSLK |
17.39 |
| ADPAMHI |
17.39 |
| SSNAFLDLRTSCFSVAALTTG |
17.39 |
| YDFVVSKG |
17.39 |
| SVTLKHFFFA |
17.39 |
| DYNYYSYN |
17.39 |
| PTMCDIKQMLFCMEVVNKYFEI |
17.39 |
| DGGCLNASEVVVNN |
17.39 |
| KARVYYESM |
17.39 |
| LKYAIS |
100.00 |
| TVAGVSILS |
41.30 |
| GATCVIGTT |
17.39 |
| LKTLYKDV |
17.39 |
| YPKCDRA |
100.00 |
| CRIFASLILARKHGTCCTT |
17.39 |
| YRLANECAQVLSEYVLCGGGYYVKPG |
17.39 |
| ANSVFNILQA |
17.39 |
| TANVSAL |
17.39 |
|
Surface accessibility prediction analysis | |
| HRHRLS |
17.39 |
| GNFNQDF |
41.30 |
| TDYNYYSYNL |
17.39 |
| ARVYYESMSYQEQD |
17.39 |
| AKNRAR |
56.52 |
| MTNRQYHQKML |
17.39 |
| TLYKDVD |
17.39 |
| WDYPKC |
100.00 |
| TRDRFY | 17.39 |